NO20060718L - Substituerte tiofoner og deres anvendelse - Google Patents
Substituerte tiofoner og deres anvendelseInfo
- Publication number
- NO20060718L NO20060718L NO20060718A NO20060718A NO20060718L NO 20060718 L NO20060718 L NO 20060718L NO 20060718 A NO20060718 A NO 20060718A NO 20060718 A NO20060718 A NO 20060718A NO 20060718 L NO20060718 L NO 20060718L
- Authority
- NO
- Norway
- Prior art keywords
- thiophones
- substituted
- cancer
- prevention
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
Abstract
Foreliggende oppfinnelse omhandler nye forbindelser som har den strukturelle formel (1) og deres farmasøytiske salter, preparater og fremgangsmåter for anvendelse. Disse nye forbindelsene tilveiebringer en behandling eller forebygging av kreft.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49558003P | 2003-08-15 | 2003-08-15 | |
US57641604P | 2004-05-28 | 2004-05-28 | |
PCT/GB2004/003473 WO2005016909A1 (en) | 2003-08-15 | 2004-08-12 | Substituted thiophenes and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20060718L true NO20060718L (no) | 2006-03-01 |
Family
ID=34198049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060718A NO20060718L (no) | 2003-08-15 | 2006-02-14 | Substituerte tiofoner og deres anvendelse |
Country Status (19)
Country | Link |
---|---|
US (2) | US7423061B2 (no) |
EP (1) | EP1660474B1 (no) |
JP (1) | JP2007502308A (no) |
KR (1) | KR20060080918A (no) |
AR (1) | AR045459A1 (no) |
AT (1) | ATE412645T1 (no) |
AU (1) | AU2004265140A1 (no) |
BR (1) | BRPI0413585A (no) |
CA (1) | CA2535652A1 (no) |
DE (1) | DE602004017478D1 (no) |
ES (1) | ES2314443T3 (no) |
HK (1) | HK1091487A1 (no) |
IL (1) | IL173619A0 (no) |
IS (1) | IS8344A (no) |
MX (1) | MXPA06001775A (no) |
NO (1) | NO20060718L (no) |
RU (1) | RU2006107782A (no) |
TW (1) | TW200524894A (no) |
WO (1) | WO2005016909A1 (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10360369A1 (de) * | 2003-12-22 | 2005-07-14 | Bayer Cropscience Ag | Amide |
JP2007517843A (ja) * | 2004-01-05 | 2007-07-05 | アストラゼネカ アクチボラグ | Chk1阻害剤であるチオフェン誘導体 |
DE102005035742A1 (de) * | 2005-07-29 | 2007-02-01 | Merck Patent Gmbh | Quadratsäurederivate II |
DE102005039541A1 (de) * | 2005-08-22 | 2007-03-22 | Merck Patent Gmbh | 3-Oxo-indazol-quadratsäurederivate |
WO2008121592A2 (en) * | 2007-03-30 | 2008-10-09 | Takeda Pharmaceutical Company Limited | Acetyl coenzyme a carboxylase inhibitors |
CN101481380B (zh) * | 2008-01-08 | 2012-10-17 | 浙江医药股份有限公司新昌制药厂 | 噻吩并哒嗪类化合物及其制备方法、药物组合物及其用途 |
WO2009096198A1 (ja) * | 2008-02-01 | 2009-08-06 | Pharma Ip Limited Liability Intermediary Corporations | 新規ビアリール誘導体 |
CN102119156B (zh) * | 2008-06-11 | 2015-01-21 | 健泰科生物技术公司 | 取代的吡咯及其使用方法 |
EP3461480A1 (en) | 2017-09-27 | 2019-04-03 | Onxeo | Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer |
EP4115883A4 (en) * | 2020-03-04 | 2024-04-10 | Pharos Ibio Co Ltd | USE OF A 2,3,5-SUBSTITUTED THIOPHENE COMPOUND TO PREVENT, MITIGATE OR TREAT OVARIAN CANCER |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1019040B1 (en) | 1997-05-23 | 2004-09-29 | Bayer Corporation | Aryl ureas for the treatment of inflammatory or immunomodulatory diseases |
AU7585598A (en) * | 1997-05-23 | 1998-12-11 | Bayer Corporation | Raf kinase inhibitors |
GB0003154D0 (en) | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
US6414013B1 (en) | 2000-06-19 | 2002-07-02 | Pharmacia & Upjohn S.P.A. | Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
WO2002030353A2 (en) | 2000-10-12 | 2002-04-18 | Smithkline Beecham Corporation | NF-λB INHIBITORS |
UA76977C2 (en) * | 2001-03-02 | 2006-10-16 | Icos Corp | Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers |
SE0102616D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
WO2003028731A1 (en) * | 2001-10-04 | 2003-04-10 | Smithkline Beecham Corporation | Chk1 kinase inhibitors |
DE60229975D1 (de) | 2001-10-04 | 2009-01-02 | Smithkline Beecham Corp | Nf-kb-inhibitoren |
WO2003029241A1 (en) * | 2001-10-04 | 2003-04-10 | Smithkline Beecham Corporation | Chk1 kinase inhibitors |
AU2003249683A1 (en) | 2002-06-06 | 2003-12-22 | Smithkline Beecham Corporation | Nf-:b inhibitors |
AU2003300832A1 (en) | 2002-12-06 | 2004-06-30 | Smithkline Beecham Corporation | NF-KappaB INHIBITORS |
SE0300091D0 (sv) | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
US20050085531A1 (en) | 2003-10-03 | 2005-04-21 | Hodge Carl N. | Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
JP2007517843A (ja) | 2004-01-05 | 2007-07-05 | アストラゼネカ アクチボラグ | Chk1阻害剤であるチオフェン誘導体 |
WO2005105777A1 (en) | 2004-05-05 | 2005-11-10 | Pharmacia & Upjohn Company Llc | Substituted thiophene amide compounds for the treatment of inflammation |
US7612200B2 (en) | 2004-12-07 | 2009-11-03 | Locus Pharmaceuticals, Inc. | Inhibitors of protein kinases |
WO2006062982A2 (en) | 2004-12-07 | 2006-06-15 | Locus Pharmaceuticals, Inc. | Urea inhibitors of map kinases |
-
2004
- 2004-08-12 KR KR1020067003164A patent/KR20060080918A/ko not_active Application Discontinuation
- 2004-08-12 JP JP2006523673A patent/JP2007502308A/ja active Pending
- 2004-08-12 AT AT04768043T patent/ATE412645T1/de not_active IP Right Cessation
- 2004-08-12 CA CA002535652A patent/CA2535652A1/en not_active Abandoned
- 2004-08-12 US US10/568,380 patent/US7423061B2/en not_active Expired - Fee Related
- 2004-08-12 ES ES04768043T patent/ES2314443T3/es active Active
- 2004-08-12 DE DE602004017478T patent/DE602004017478D1/de not_active Expired - Fee Related
- 2004-08-12 MX MXPA06001775A patent/MXPA06001775A/es not_active Application Discontinuation
- 2004-08-12 WO PCT/GB2004/003473 patent/WO2005016909A1/en active Search and Examination
- 2004-08-12 RU RU2006107782/04A patent/RU2006107782A/ru not_active Application Discontinuation
- 2004-08-12 BR BRPI0413585-7A patent/BRPI0413585A/pt not_active Application Discontinuation
- 2004-08-12 AU AU2004265140A patent/AU2004265140A1/en not_active Abandoned
- 2004-08-12 EP EP04768043A patent/EP1660474B1/en active Active
- 2004-08-13 TW TW093124393A patent/TW200524894A/zh unknown
- 2004-08-17 AR ARP040102946A patent/AR045459A1/es unknown
-
2006
- 2006-02-08 IL IL173619A patent/IL173619A0/en unknown
- 2006-02-14 NO NO20060718A patent/NO20060718L/no not_active Application Discontinuation
- 2006-03-09 IS IS8344A patent/IS8344A/is unknown
- 2006-11-01 HK HK06112029.4A patent/HK1091487A1/xx not_active IP Right Cessation
-
2008
- 2008-09-08 US US12/206,317 patent/US20090054396A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AR045459A1 (es) | 2005-10-26 |
AU2004265140A1 (en) | 2005-02-24 |
HK1091487A1 (en) | 2007-01-19 |
DE602004017478D1 (de) | 2008-12-11 |
ATE412645T1 (de) | 2008-11-15 |
BRPI0413585A (pt) | 2006-10-17 |
RU2006107782A (ru) | 2006-08-10 |
EP1660474B1 (en) | 2008-10-29 |
JP2007502308A (ja) | 2007-02-08 |
IS8344A (is) | 2006-03-09 |
US20060281666A1 (en) | 2006-12-14 |
ES2314443T3 (es) | 2009-03-16 |
WO2005016909A1 (en) | 2005-02-24 |
US20090054396A1 (en) | 2009-02-26 |
US7423061B2 (en) | 2008-09-09 |
TW200524894A (en) | 2005-08-01 |
IL173619A0 (en) | 2006-07-05 |
CA2535652A1 (en) | 2005-02-24 |
EP1660474A1 (en) | 2006-05-31 |
KR20060080918A (ko) | 2006-07-11 |
MXPA06001775A (es) | 2006-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20060718L (no) | Substituerte tiofoner og deres anvendelse | |
NO20063449L (no) | Substituerte heterocykler og deres anvendelse | |
NO20055219L (no) | Nye forbindelser | |
NO20054083L (no) | Nye sammenkoblede triazoloner og deres anvendelse | |
NO20055568L (no) | Substituerte 1,4-diazepiner og anvendelser derav | |
NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
NO20070557L (no) | Ftalazinderivater som PARP-inhibitorer | |
NO20050828L (no) | lndol-3-svovelderivater | |
NO20081454L (no) | Met-kinaseinhibitorer | |
NO20054340L (no) | Nye sammenkoplede heterocykler og deres anvendelse | |
BRPI0410630A (pt) | antagonista de nk1 | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
NO20062021L (no) | Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika | |
NO20063468L (no) | Triazolforbindelser og deres anvendelse som metabotrofe glutamatreseptorantagonister | |
NO20055688L (no) | Organiske forbindelser | |
NO20090755L (no) | Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens | |
NO20050134L (no) | Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse | |
NO20060195L (no) | Kinolylamidderivater som CCR-5-antagonister | |
NO20054787L (no) | Indenderivater som farmasotiske midler | |
NO20076479L (no) | Nye oksadiazolderivater og anvendelse derav som positive allosteriske metabotropiske modulatorer av glutamatreseptorer | |
NO20071137L (no) | Nye piperidinderivater for behandling av depresjon | |
NO20076638L (no) | Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |